Login / Signup

Development of a flexible, sweat-based neuropeptide Y detection platform.

Nathan Kodjo Mintah ChurcherSayali UpashamPaul RiceSerena BhadsavleShalini Prasad
Published in: RSC advances (2020)
Neuropeptide Y (NPY) biomarker levels have a close association with the diagnosis of Major Depression Disorder (MDD) and anxiety disorders. Quantifying NPY in correlation to self-reported symptoms will be an important measure to ensure a relatively uniform diagnosis and help with disease prognosis of these disorders. The work presented is a novel, passive eccrine sweat based, electrochemical detection platform for quantification of NPY biomarker levels. The paper offers a comparison between non-porous and porous sensor platforms using various electrochemical detection techniques. This work uses a novel strategy towards designing an optimal nanobioelectronic interface to measure NPY. The portability aspect of this detection platform is discussed by the demonstration a novel, portable EmStat Pico based electronic platform. The detection limit of the sensor is 10 pg mL -1 and its range is 20-500 pg mL -1 . The NPY detection platform is envisioned to be a wearable point-of need monitoring system for management of chronic anxiety disorders and MDD.
Keyphrases
  • label free
  • loop mediated isothermal amplification
  • real time pcr
  • major depressive disorder
  • heart rate
  • drug induced